Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Likewise.Fifteen posts in an hour is not ‘normal’ Charts are merely open to how one interprets them and its posting is not as innocuous as it makes out with it stating certain interpreted charting positions as definitive fact in attempting to ensure a retrace here along with making definitive statements about news timelines which will enable short positions to prosper in the interim which it has no clue about whatsoever any more than any other here.The ‘fact’ is company transformational news could drop any trading day this year including today and these posts are misleading to potential new investors and designed to disrupt and scaremonger in order to meet its very transparent agenda of having sold and angling big time for a cheaper re-entry.Manipulative bombardment should not be tolerated.Only our Ceo knows what is ‘fact’ in total.
Last shake of the days on… will we see 50/100k buyer appear they paid 57p this morning!
Our market cap is very cheap. We are still only 37 million which is nothing at the moment. 100 million a real possibility after the first deal especially if it is Marck or Astrazeneca which I think it will be. FOMO should kick in for deal 2 and 3 after the first one and we only have about 65 million shares.
RNS is close so expecting some strong rises along the way. Not selling any for a long time simply not worth it as downside is very low compared to potential upside provided the deal comes.
Looking like we are going to tick up out of the 9 o’clock auction….. at what price is anyone’s guess.
If anyone knows Mr Ells can you please check on him im concerned apparantly he was on the phone to the Samaritans last night lol
It would be amazing if we can reach last years heights of 74p before we get the golden RNS :)
Let’s see if they are willing to pay 57p all day, if so it’s going to be a good one.
Agreed Rightback - to be buying 50k or 100k tranches of shares at the current SP is a serious amount of money… My first purchase of 50k was at 13p and at the time I thought that was a lot of money - obviously though it’s all in relation to how deep ones pockets are to start with….
GLA
Morning all
This is what I have been waiting for and it’s very enjoyable..
I would just like to say a “polite board” is far more welcoming to new investors… me thinks
Rb your comments last night made me laugh…
Wishing everyone a great day :)
OB
Wow
50/100k buyers back again they must show there cards soon.
Morning all.
Morning all lets see What Valirx has to offer today so far excellent start. GLA
Was looking for a better way of expressing this, but if the cap fits-You really are a Tedious Tw—-at who just loves to pull a poster up on a slightly wrong prediction on one particular day ffs.The trend is upward and just be glad to be part of and benefit from this transformational re-rate if indeed you do hold.Clever Trevor -and boring!!
Porky,
RE you 04:09 post today,
You said something similar on Friday - you won't need reminding how wrong you were that day.
I can't help thinking your forecast is based - in part, on 'wishful thinking'.
That said, I hope you're right.
Agreed Josh, I'm expecting a massive week for this stock. Market cap materially undervalued at just £ 35m market cap at 55pand the Share Price now finally in break out... starting to get noticed... volumes increasing.... all looking great.
Upside stratospheric frankly
https://twitter.com/Porky9Here/status/1453231875418374146
The trial data for 201 alone was superb, it was proven to have a clear impact on patients with prostate cancer. The license deal on 201 will likely dwarf the current mcap of this business many times over.
For those not keeping up, In prostate cancer, the hope is that the 201 drug will be able to control tumours that no longer respond to other treatments like radiotherapy as well as androgen-inhibiting drugs like flutamide or bicalutamide. The prognosis for these patients is typically very poor, with less than half of them surviving beyond two years.
“Development of effective treatments with low-side effects for patients with prostate cancer who have relapsed after radiotherapy is essential and will improve the lives of patients during treatment,” said Professor Alan Boyd, who was the consultant pharmaceutical physician and medical monitor for the earlier study.
In addition 301 could also license anytime soon:-
It has the same peptide ingredient as 201 and is being investigated for the treatment of women with endometriosis in preclinical development, again another major advancing drug.
All to play for here as i see it, I am incredibly bullish.. the deal on 201 will take us well north of £1 a £65m mcap, if 301 concludes in addition before end of the year end then seriously £150m mcap is not impossible to imagine from here
GLA
You can expect nothing less than a positive message from me to start the Wednesday session off but based on previous patterns its looking like today will be a MAJOR buying day for this stock towards the next leg of the journey.
https://twitter.com/Porky9Here/status/1453194787545354245/photo/1
We have had the two red days the retrace and now its onwards to the next level. I’m going for an 8p to 10p+ rise today and joining the leaders board.
Stock moving to sticky hands, reducing free flow and another day closer to news. We are also due some other updates that will also boost value imo. This week is going to be a VERY positive week for this stock.
I feel more bullish today than Captain Bullish of the good ship bullish sailing to the land of bullishness with a crew of bullish people. So be warned, if positivity is not your thing best switch off now because we are moving on up....
Bring it on….
Pork’s